Thinking beyond intravenous immunoglobulin for Kawasaki disease

被引:0
作者
Sage, Anne [1 ]
Jindal, Ankur Kumar [2 ]
Ramanan, Athimalaipet, V [1 ]
机构
[1] Bristol Royal Hosp Children, Dept Paediat Rheumatol, Bristol, England
[2] Post Grad Inst Med Educ & Res, Pediat, Chandigarh, India
关键词
Allergy and Immunology; Emergency Service; Hospital; Health Care Economics and Organizations; Paediatrics; Rheumatology;
D O I
10.1136/archdischild-2023-325843
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:781 / 782
页数:2
相关论文
共 7 条
[1]   Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE [J].
Iio, Kazuki ;
Morikawa, Yoshihiko ;
Miyata, Koichi ;
Kaneko, Tetsuji ;
Misawa, Masahiro ;
Yamagishi, Hiroyuki ;
Miura, Masaru .
JOURNAL OF PEDIATRICS, 2022, 240 :158-+
[2]   Phase II Open-Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease [J].
Kone-Paut, Isabelle ;
Tellier, Stephanie ;
Belot, Alexandre ;
Brochard, Karine ;
Guitton, Corinne ;
Marie, Isabelle ;
Meinzer, Ulrich ;
Cherqaoui, Bilade ;
Galeotti, Caroline ;
Boukhedouni, Nadja ;
Agostini, Helene ;
Arditi, Moshe ;
Lambert, Virginie ;
Piedvache, Celine .
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (01) :151-161
[3]   Infliximab for intensi?cation of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis [J].
Miyata, Koichi ;
Bainto, Emelia, V ;
Sun, Xiaoying ;
Jain, Sonia ;
Dummer, Kirsten B. ;
Burns, Jane C. ;
Tremoulet, Adriana H. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (10) :833-838
[4]   Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial [J].
Portman, Michael A. ;
Dahdah, Nagib S. ;
Slee, April ;
Olson, Aaron K. ;
Choueiter, Nadine F. ;
Soriano, Brian D. ;
Buddhe, Sujatha ;
Altman, Carolyn A. ;
Del Toro, Kamill ;
Kourtidou, Soultana ;
Wisotzkey, Bethany ;
Bruce, Margaret ;
Cox, Jennifer ;
Williams, Richard ;
Reeder, Jamie ;
Kirkpatrick, Edward ;
Malloy, Marsha ;
Krolikowslki, Mary ;
Briere, Julie ;
Breault, Fabiola ;
Rajan, Sujatha ;
Mensch, Deborah ;
Stellato, Nancy ;
Rubin, Lorry ;
Sood, Sunil ;
Leibowitz, Jill ;
Shah, Rita ;
Soma, Vijaya ;
Cooper, Rubin ;
DeMers, Christine ;
Sexson-Tejtel, Sara K. ;
Griffin, Debra ;
Shittu, Teniola ;
Munjal, Iona ;
Balem, Kelly Ann ;
Imundo, Lisa ;
Isgro, Josephine ;
Ferris, Anne ;
Slee, April .
PEDIATRICS, 2019, 143 (06)
[5]   Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial [J].
Tremoulet, Adriana H. ;
Jain, Sonia ;
Jaggi, Preeti ;
Jimenez-Fernandez, Susan ;
Pancheri, Joan M. ;
Sun, Xiaoying ;
Kanegaye, John T. ;
Kovalchin, John P. ;
Printz, Beth F. ;
Ramilo, Octavio ;
Burns, Jane C. .
LANCET, 2014, 383 (9930) :1731-1738
[6]   Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015 [J].
Tulloh, Robert M. R. ;
Mayon-White, Richard ;
Harnden, Anthony ;
Ramanan, Athimalaipet V. ;
Tizard, E. Jane ;
Shingadia, Delane ;
Michie, Colin A. ;
Lynn, Richard M. ;
Levin, Michael ;
Franklin, Orla D. ;
Craggs, Pippa ;
Davidson, Sue ;
Stirzaker, Rebecca ;
Danson, Mike ;
Brogan, Paul A. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (07) :640-646
[7]   Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease [J].
Vande Casteele, Niels ;
Oyamada, Jun ;
Shimizu, Chisato ;
Best, Brookie M. ;
Capparelli, Edmund V. ;
Tremoulet, Adriana H. ;
Burns, Jane C. .
CLINICAL PHARMACOKINETICS, 2018, 57 (12) :1593-1601